Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Cohn

Showing results (361-370 of 612) with videos related to

Pageof 62
Sort By:
Plos One|April 22, 2020
Tuberculosis and foreign-born populations in the United States: A mixed methods pilot study of media reporting and political identificationAngel N Desai, Shravanthi M Seshasayee, Maimuna S Majumder, et al.
European Journal of Clinical Pharmacology|January 1, 1984
Haemodynamic effects of oral molsidomine in pump failure complicating myocardial infarctionS Drajer, H Cercós, H Torres, et al.
The Journal of Infectious Diseases|November 1, 1988
Class-specific antibody response to pneumococcal capsular polysaccharides in men infected with human immunodeficiency virus type 1E N Janoff, J M Douglas, M Gabriel, et al.
JCO Clinical Cancer Informatics|October 15, 2020
Tailoring Therapy for Children With Neuroblastoma on the Basis of Risk Group Classification: Past, Present, and FutureWayne H Liang, Sara M Federico, Wendy B London, et al.
Journal of Acquired Immune Deficiency Syndromes|January 1, 1989
Comparison of AIDS and HIV antibody surveillance data in ColoradoR E Hoffman, S E Valway, F C Wolf, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 30, 2004
Association of epigenetic inactivation of RASSF1A with poor outcome in human neuroblastomaQiwei Yang, Peter Zage, David Kagan, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|September 18, 2003
When to begin highly active antiretroviral therapy? Evidence supporting initiation of therapy at CD4+ lymphocyte counts <350 cells/microLJonathan E Kaplan, Debra L Hanson, David L Cohn, et al.
Nanoscale Advances|September 22, 2022
Biomimetic strategies to produce catalytically reactive CuS nanodisksElise C Bell, Catherine J Munro, Joseph M Slocik, et al.
Epigenetics|August 9, 2022
MYCN and HIF-1 directly regulate <i>TET1</i> expression to control 5-hmC gains and enhance neuroblastoma cell migration in hypoxiaAnastasia E Hains, Sakshi Uppal, John Z Cao, et al.
The Western Journal of Medicine|August 1, 1984
Health status of Southeast Asian refugeesF N Judson, D M Lince, B J Anders, et al.
Pageof 62

Showing results (361-370 of 612) with videos related to

Sort By:
Pageof 62
Plos One|April 22, 2020
Tuberculosis and foreign-born populations in the United States: A mixed methods pilot study of media reporting and political identificationAngel N Desai, Shravanthi M Seshasayee, Maimuna S Majumder, et al.
European Journal of Clinical Pharmacology|January 1, 1984
Haemodynamic effects of oral molsidomine in pump failure complicating myocardial infarctionS Drajer, H Cercós, H Torres, et al.
The Journal of Infectious Diseases|November 1, 1988
Class-specific antibody response to pneumococcal capsular polysaccharides in men infected with human immunodeficiency virus type 1E N Janoff, J M Douglas, M Gabriel, et al.
JCO Clinical Cancer Informatics|October 15, 2020
Tailoring Therapy for Children With Neuroblastoma on the Basis of Risk Group Classification: Past, Present, and FutureWayne H Liang, Sara M Federico, Wendy B London, et al.
Journal of Acquired Immune Deficiency Syndromes|January 1, 1989
Comparison of AIDS and HIV antibody surveillance data in ColoradoR E Hoffman, S E Valway, F C Wolf, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 30, 2004
Association of epigenetic inactivation of RASSF1A with poor outcome in human neuroblastomaQiwei Yang, Peter Zage, David Kagan, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|September 18, 2003
When to begin highly active antiretroviral therapy? Evidence supporting initiation of therapy at CD4+ lymphocyte counts <350 cells/microLJonathan E Kaplan, Debra L Hanson, David L Cohn, et al.
Nanoscale Advances|September 22, 2022
Biomimetic strategies to produce catalytically reactive CuS nanodisksElise C Bell, Catherine J Munro, Joseph M Slocik, et al.
Epigenetics|August 9, 2022
MYCN and HIF-1 directly regulate <i>TET1</i> expression to control 5-hmC gains and enhance neuroblastoma cell migration in hypoxiaAnastasia E Hains, Sakshi Uppal, John Z Cao, et al.
The Western Journal of Medicine|August 1, 1984
Health status of Southeast Asian refugeesF N Judson, D M Lince, B J Anders, et al.
Pageof 62